MedTrace Logo

Efficacy of Valproate in Peripheral Neuropathic Pain

NCT00221637 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-06-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether valproate is effective and well tolerated in the treatment of neuropathic peripheral pain. The drug is administered by intravenous route followed by oral route during 4 weeks.

Conditions

  • Neuralgia
  • Neuropathic Peripheral Pain

Interventions

DRUG

Sodium Valproate

Sponsors & Collaborators

  • Sanofi-Synthelabo

    collaborator INDUSTRY

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Virginie Dousset, Dr · University Hospital, Bordeaux

  • Paul Perez, Dr · University Hospital, Bordeaux

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Completion
2005-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00221637 on ClinicalTrials.gov